News

Fewer biopsies, happier patients: Why molecular blood testing is a game-changer for managing heart transplant recipients

Follow-up care after a successful heart transplant can be challenging—both for providers and their patients. Consider, for example, the fact that so many patients who develop complications never actually present with symptoms.

Patients are discussing whole-body MRIs on Reddit, presenting opportunity for radiologists

“Radiologists are well-positioned to contribute evidence-based guidance, promote transparency, and help patients make informed decisions," experts write in Clinical Imaging.

Lumexa acquires imaging center as part of new joint venture with UPMC

Lumexa hopes to open between 8 to 10 newly constructed, “de novo” centers in 2026, including multiple ones built in partnership with UPMC.

Novel urine test reduces need for MR imaging, prostate biopsies

Vanderbilt experts have developed an assessment called MyProstateScore 2.0, which they say performs better than regular PSA-based testing and MRI for monitoring low-risk disease.

Investor-bought PCPs carry on like nothing much has changed—with caveats

Private-equity acquisitions of primary-care provider practices neither alter hospitalization rates nor affect acute-care outcomes, according to new research out of Brown University.

12 of the top technology vendors serving children’s hospitals

Epic makes the list with its enterprise inpatient EHR and related platforms. So does PCC, aka Physician’s Computer Company, which supplies pediatric-specific ambulatory EHR and practice-management products and services.

Siemens Healthineers nabs FDA clearance for 6 new IR systems

Siemens Healthineers scores FDA clearance for 6 interventional systems

Each device comes equipped with a new AI feature designed to deliver high quality imaging at lower radiation doses during IR procedures.

Half of emergency CT requests for children may not adhere to imaging appropriateness criteria

The overuse of CT scans on kids could be owed, at least in part, to the fear of missing a critical finding, new research suggests.

Medtronic's Evolut Pro TAVR valve treating aortic stenosis

TAVR linked to higher reintervention rate than SAVR in Evolut Low Risk trial update

The Evolut Low Risk trial has been one of cardiology’s most closely watched studies for years now. For the first five years after treatment, TAVR and SAVR were associated with comparable outcomes when treating low-risk patients. In this new six-year update, however, TAVR was linked to a heightened risk of reintervention not seen with SAVR.

Bayer: Aiding Customer Resilience Amid CT Disruption

U.S. Radiology departments navigating CT market challenges—supply disruptions and rising demand for contrast and delivery—need reliable partners. Hear Bayer leads explain how Bayer helps provide steady supply and innovations to support CT imaging and patient care.

The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for a 12-lead electrocardiogram (ECG) synthesis software for home assessment of arrhythmias. This clearance follows HeartBeam’s successful appeal of a prior "not substantially equivalent (NSE) determination.

FDA clears 12-lead, cable-free home ECG monitoring system

The new technology synthesizes signals from a credit card-sized device into a 12-lead ECG representation.

Private equity activity ‘steady’ in 2025, with a dozen-plus deals in diagnostic imaging

The Private Equity Stakeholder Project estimates there were 1,029 such transactions across the entire healthcare sector last year.

Around the web

Cardiovascular Business